Jeryl L. Hilleman, Chief Financial Officer at Intersect ENT, Inc. (XENT), sold 30,000 shares at $32.07 ($962K) on 2019-04-01, disclosed to the SEC on 2019-04-03.
Open-market sale of $962k XENT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SIBN | SELL | 2023-06-20 | $178K | — | Filing → |
| NVCR | SELL | 2022-06-16 | $28K | — | Filing → |
| SIBN | SELL | 2022-06-14 | $27K | — | Filing → |